id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-10232-0001,FDA,FDA-2026-N-10232,"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—2027
Southern Hemisphere Influenza Virus Vaccines",Notice,Request for Comments,2026-09-09T04:00:00Z,2026,9,2026-09-09T04:00:00Z,2026-09-30T03:59:59Z,2026-09-20T09:00:22Z,2026-18349,0,0,09000064b9506dd6